EPA and DHA: what each one does and how much you really need

⏱ 6 min read

A recent editorial report (Medical Xpress, 2026) highlighted growing interest in whether increasing omega‑3 intake can support recovery and long‑term health in athletes. Behind the headlines are two long‑chain omega‑3 fatty acids, EPA and DHA, that form part of cell membranes, influence inflammation signalling, and contribute to heart, brain and eye function. This guide explains their roles, the most relevant benefits, where to find them in food, what research supports, and how to think about supplements sensibly.

EPA and DHA in plain terms: what they do in the body

EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are long‑chain omega‑3 fatty acids found mainly in marine foods. They become part of cell membranes and are used to form signalling molecules that can influence inflammatory activity. DHA is especially concentrated in the brain and retina, where it contributes to normal function and structure.

The body can convert some plant omega‑3 (ALA from flax or chia) into EPA and DHA, but the conversion is limited and variable. Direct intake from fish, seafood, algae, or a standardised supplement therefore provides a more predictable amount.

Key benefits backed by research

Research covers several outcome areas. The strongest and most practical findings cluster around heart health, blood lipids, and emerging performance‑recovery questions.

Heart and circulation

EPA and DHA have been associated with favourable cardiovascular markers. An American Heart Association science advisory summarised that prescription‑strength omega‑3 can lower triglycerides substantially in people with hypertriglyceridaemia (Skulas‑Ray et al., 2019). In a large outcomes trial using a purified EPA formulation (4 g/day), cardiovascular events were reduced in selected high‑risk patients on statins (Bhatt et al., 2019). Population‑level reviews find more modest effects and stress context, dose, and baseline risk (Abdelhamid et al., 2020).

Blood lipids (triglycerides)

Across controlled studies, EPA+DHA intakes in the gram range can reduce fasting triglycerides, often by 15-30% depending on baseline levels and formulation (Skulas‑Ray et al., 2019). This effect is one of the most consistent findings and explains why clinicians consider omega‑3 when triglycerides remain elevated.

Inflammation and recovery

EPA‑derived mediators help resolve inflammatory activity, while DHA contributes to similar resolution pathways (Calder, 2020). In sport, reviews discuss potential benefits for muscle soreness, joint comfort, and recovery dynamics, although results vary with dose, duration, and training load (Heileson, 2020). The athletic‑health angle mentioned by Medical Xpress (2026) reflects this ongoing interest.

Brain and eyes

DHA is a structural component of neural and retinal tissue. Observational and interventional studies link adequate DHA to normal visual and cognitive development in infants and to visual function across life, while adult cognitive outcomes show mixed findings across trials (Schaefer et al., 2006; updated narrative reviews summarised by Calder, 2020). For a dedicated deep‑dive into DHA specifically, see the guide “What is DHA?” [Internal link: https://herbano.com/eu/blog/what-is-dha].

Food sources and practical intake

Marine foods provide the most reliable EPA and DHA. Oily fish are typically at the top; content varies by species, cut and season.

Food (typical serving)	Approx. EPA+DHA	Notes
Salmon (100 g cooked)	~1.2-1.8 g	Varies with wild/farmed and fat content
Mackerel (100 g)	~1.0-1.5 g	Rich, also provides vitamin D
Sardines (100 g)	~1.0-1.5 g	Canned in water or olive oil are practical
Herring (100 g)	~1.5-2.0 g	Content varies with preparation
Tuna (100 g)	~0.2-1.0 g	Lower than oily fish; variable across species
Algal oil (1 portion)	~0.2-0.6 g DHA	Plant‑origin DHA; some products include EPA

Plant sources such as flax, chia and walnuts provide ALA rather than EPA/DHA. ALA is still nutritionally relevant, but relying on conversion alone may not provide a predictable EPA+DHA amount.

Relative EPA+DHA content

Salmon

Mackerel

Sardines

Tuna

Flax (ALA)

Schematic representation

How much EPA and DHA are commonly studied?

For general dietary guidance, international bodies often describe intakes of around 250-500 mg/day of combined EPA+DHA for adults through food patterns. Clinical trials investigating triglyceride reduction or particular outcomes frequently use higher intakes and purified formulations. As one example, the REDUCE‑IT trial tested 4 g/day of an EPA‑only prescription product in high‑risk patients on statins (Bhatt et al., 2019). Sport‑recovery studies often range from ~1-3 g/day EPA+DHA for several weeks (Heileson, 2020).

The suitable amount depends on the purpose (dietary adequacy vs. targeted outcome), baseline intake, health status, and product type. Prescription products and medical treatments follow clinical supervision. For over‑the‑counter supplements, standardised, batch‑tested products help quantify actual EPA and DHA per capsule.

 

Choosing an omega‑3 supplement: simple criteria

When diet does not meet intake goals or a targeted, consistent dose is desired, a standardised omega‑3 capsule is a practical option. The following criteria help compare products quickly.

1

EPA/DHA per serving

Check combined milligrams per daily serving rather than total fish oil

2

Purity & testing

Prefer products with oxidation measures and contaminant testing

3

Formulation

Ethyl ester or triglyceride forms are both used; consistent intake matters more than small form differences

4

Capsule count

Confirm how many capsules equal the stated daily amount

5

Additions

Mixed tocopherols and antioxidants can support stability; avoid unnecessary flavours/dyes

Where joint comfort, triglycerides, or recovery are primary goals, consistent daily intake over several weeks is more informative than sporadic use. Standardised capsules ensure a known amount of EPA and DHA without relying on fluctuating food content.

Editorial bridge to products: Consistent EPA and DHA intake is easier when the amount per serving is clear and stable. A high‑quality omega‑3 capsule offers a defined dose, batch testing and convenience alongside a fish‑rich diet.

[Product-Slider: Omega‑3 capsules]

What omega‑3 can and cannot do

EPA and DHA support several physiological processes. The evidence is strongest for lowering triglycerides and for roles in cardiovascular risk management under defined clinical conditions, with more variable results across general populations. For muscle soreness and recovery, reviews indicate potential benefits that depend on dose, duration and training context. Omega‑3 should not be seen as a replacement for indicated medical therapy, sleep, nutrition, or training structure; it is a supportive component that can make a measurable difference when used correctly.

After 1-2 weeks Early changes in perceived soreness for some contexts

After 4-8 weeks Lipid markers such as triglycerides are reassessed

After 3-6 months Long‑term patterns and adherence matter most

Summary: the essential points

• EPA and DHA integrate into cell membranes and influence inflammatory signalling; DHA also supports brain and retinal structure.
• Strongest outcomes: lowering triglycerides and cardiovascular risk in specific high‑risk settings; mixed results in general populations.
• Oily fish remain the richest food sources; algal oils supply DHA (and sometimes EPA) for plant‑origin options.
• General dietary guidance for adults often centres on 250-500 mg/day EPA+DHA through food; targeted trials use higher, defined doses.
• For predictable intake, choose a standardised omega‑3 supplement with clear EPA/DHA per serving, purity testing and stable formulation.

Conclusion

The central idea is straightforward: EPA and DHA from marine sources integrate into cell membranes and help shift signalling towards resolving inflammation, with clear effects on triglycerides and defined roles in cardiovascular care and recovery contexts. In practical terms, plan 1-2 servings of oily fish per week or use a standardised omega‑3 supplement to secure a consistent daily EPA+DHA intake. Track lipid markers after 4-8 weeks where relevant, and keep sleep, protein intake and training structure aligned with recovery goals. For a reliable daily dose without relying on variable food content, a high‑quality omega‑3 capsule supplying defined EPA and DHA per serving is a convenient way to support heart, brain, eye and recovery needs alongside a balanced diet.

Frequently asked questions

Is plant omega‑3 (ALA) the same as EPA and DHA?

Not exactly. ALA from flax, chia and walnuts is valuable, but conversion to EPA and DHA is limited and variable. Direct sources of EPA and DHA, fish, seafood, algae, or standardised supplements, provide a more predictable intake.

What is the difference between EPA and DHA in simple terms?

EPA is often linked to effects on inflammatory signalling and blood lipids, while DHA is a structural component concentrated in the brain and eyes. Most supplements provide both because they play complementary roles.

Can omega‑3 help with exercise recovery?

Reviews in sports nutrition discuss potential benefits for soreness and recovery dynamics when adequate EPA+DHA is consumed consistently for several weeks (Heileson, 2020). Results vary with dose, training load and study design.

Are capsules as good as fish?

They serve different purposes. Fish provides EPA/DHA plus protein, selenium and often vitamin D. Capsules provide a measured dose of EPA/DHA that is consistent day to day and independent of fish availability or preferences.

How long until changes are seen?

For lipid markers such as triglycerides, reassessment typically occurs after 4-8 weeks. Perceived soreness changes, where they occur, may be reported earlier. Time frames guide expectations and are not guarantees.

What about safety and interactions?

Omega‑3 supplements are widely used. People with bleeding disorders, those on anticoagulant therapy, or those preparing for surgery require medical guidance. Prescription products follow clinical supervision and specific dosing.

Sources (in English):

Abdelhamid, A. S., et al. (2020). Omega‑3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews, (3):CD003177.

Bhatt, D. L., et al. (2019). Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. New England Journal of Medicine, 380(1):11-22.

Calder, P. C. (2020). Omega‑3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions, 48(1):5-13.

Heileson, J. L. (2020). Omega‑3 fatty acids and exercise. Current Sports Medicine Reports, 19(10):413-414.

Skulas‑Ray, A. C., et al. (2019). Omega‑3 fatty acids for the management of hypertriglyceridemia: A science advisory from the American Heart Association. Circulation, 140(12):e673–e691.

Schaefer, E. J., et al. (2006). Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer’s disease. American Journal of Clinical Nutrition, 83(6):1337-1343.